Immunovant IMVT reported its Q2 earnings results on Friday, November 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Immunovant missed estimated earnings by 5.13%, reporting an EPS of $-0.41 versus an estimate of $-0.39.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 8.68% increase in the share price the next day.
To track all earnings releases for Immunovant visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.